Scientific Advisory Group on Immune and Inflammatory Diseases

The Scientific Advisory Group on Immune and Inflammatory Diseases (SAG-IMM)'s role is to provide independent recommendations on scientific, clinical or technical matters to the European Medicine Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP). These recommendations refer to medicines addressing autoimmune, inflammatory diseases, respiratory and dermatological diseases, or any other scientific issues. The scientific advisory group is convened at the request of the CHMP.

The Scientific Advisory Group on Immune and Inflammatory Diseases provides recommendations for medicines under CHMP evaluation. 

These include medicines for autoimmune and inflammatory diseases like immunodeficiencies, rheumatology, transplantation and allergies. They also refer to medicines for respiratory and dermatological diseases.

The group's recommendations also cover other scientific issues relevant to the CHMP's work in this field.

For more information on CHMP working parties and group, see: 

• CHMP: Working parties and other groups

Mandate, rules of procedure and work programme

Information on the group's mandate, objectives and rules of procedure is available below:

Mandate, objectives and rules of procedure for the Scientific Advisory Groups (SAGs) and ad-hoc experts groups

Adopted Reference Number: EMA/117014/2010

Composition

The group will be composed of independent European experts selected according to their specific expertise. 

It will comprise a core group of experts and other individual experts who may be called upon to participate in a given meeting and bring additional expertise in specific domains.

Call for members

EMA launched a public call for expressions of interest to establish the Scientific Advisory Group for Immune and Inflammatory Diseases. 

Those interested to become members of this scientific advisory group should apply before 17 October 2025 via [e-mail]. 

CHMP endorsed the group in June 2025.

EMA launched this call for members in August 2025.

EMA expects the group to become operational in Q4 2025. 

Selection criteria and other application details are available in the document below summarising the public call for members.

Those interested should fill in a declaration of interest form also available below:

Public call for expression of interest for experts to become members of the European Medicines Agency's Scientific Advisory Group on Immune and Inflammatory Diseases

Reference Number: EMA/217895/2025

To open the declaration form below, you need to use a PDF reader. You should save the document first, then open it with a PDF reader such as Acrobat Reader.

Declaration of interest form: Public call for Scientific Advisory Group on Immune and Inflammatory Diseases